Perioperative Management of the Facial Wounds with Insight of Scar Prevention
Main Article Content
Abstract
Human face is the front side of a head which functions most of all for individual identity. Global culture agrees that scarring on the face reduces attractiveness to the opposite sex; and it drives everyone with a wound or a proposed wound on his/her face to ask for a favorable scar. Clinical management of incisional scars begins with a thorough discussion of surgical pre-measures. The main modifiable factor of scar formation is the design of the skin incision that bears the least tension in the healing period. During surgical procedures, doctors must pay attention to skin tension lines and vascularization to the wound edge tissues. After the surgical procedure, sutures with non-absorbable materials must be taken off, and skin tape must be applied perpendicularly to the wound axis to reduce tensions during the remodeling phase of healing. The patients’ active participation in wound management, even long after the wound appears to heal, support good outcomes. Post-surgical evaluation visits must be conducted and focus on the prevention, early detection, and proper management of the healing wound, especially ones with hypertrophic potential. Hypertrophic scars which do not improve after six months is no longer considered hypertrophic scars but it is considered keloids which require proactive and more intensive management.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Burriss RP, Rowland HM, Little AC. Facial scarring enhances men’s attractiveness for short-term relationships. Personality and Individual Differences 2009;46:213-7.
II. Almine JF, Wise SG, Weiss AS. Elastin signaling in wound repair. Birth Defects Res C Embryo Today 2012;96:248–57.
III. Bae SH, Bae YC, Nam SB, Choi SJ. A skin fixation method for decreasing the influence of wound contraction on wound healing in a rat model. Arch Plast Surg 2012;39:457–62.
IV. Larson BJ, Longaker MT, Lorenz HP. Scarless fetal wound healing: a basic science review. Plast Reconstr Surg 2010;126:1172–80.
V. Kim HY, Kim JW, Park JH, Kim JH, Han YS. Personal factors that affect the satisfaction of female patients undergoing esthetic suture after typical thyroidectomy. Arch Plast Surg 2013;40:414–24.
VI. Toll EC, Loizou P, Davis CR, Porter GC, Pothier DD. Scars and satisfaction: do smaller scars improve patient-reported outcome? Eur Arch Otorhinolaryngol 2012;269:309–13.
VII. Chu HJ, Son DG, Kwon SY, Kim JH, Han KH. Characteristics of wound contraction according to the shape and antomical regions of the wound in porcine model. J Korean Soc Plast Reconstr Surg 2011;38:576–84.
VIII. Langer K. On the anatomy and physiology of the skin: II. Skin tension. Br J Plast Surg 1978;31:93.
IX. Wilhelmi BJ, Blackwell SJ, Phillips LG. Langer's lines: to use or not to use. Plast Reconstr Surg
X. 1999;104:208–14.
XI. Borges AF. Relaxed skin tension lines (RSTL) versus other skin lines. Plast Reconstr Surg 1984;73:144–50.
XII. Borges AF. Relaxed skin tension lines. Dermatol Clin 1989;7:169–77.
XIII. Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: Experimental study and clinical applications. British Journal of Plastic Surgery. 1987;40:113-141
XIV. Saint-Cyr M, Wong C, Schaverien M, et al. The perforasome theory: Vascular anatomy and clinical implications. Plastic and Reconstructive Surgery. 2009;124(5):1529-1544
XV. Taylor GI, Corlett RJ, Dhar SC, Ashton MW. The anatomical (angiosome) and clinical territories of cutaneous perforating arteries: Development of the concept and designing safe flaps. Plastic and Reconstructive Surgery. 2011;127(4):1447-1459
XVI. Alsharnoubi J, Shoukry KE, Fawzy MW, Mohamed O. Evaluation of scars in children after treatment with low-level laser. Lasers Med Sci 2018 Dec;33(9):1991-5
XVII. Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H. Keloids: current concepts of pathogenesis (review) Int J Mol Med 2009;24:283–93.
XVIII. Oluwasanmi JO. Keloids in the African. Clin Plast Surg 1974;1:179–95.
XIX. Sun LM, Wang KH, Lee YC. Keloid incidence in Asian people and its comorbidity with other fibrous-related diseases: a nationwide population-based study. Arch Dermatol Res 2014;306(9):803-8.
XX. Bush JA, McGrouther DA, Young VL, Herndon DN, Longaker MT, Mustoe TA, Ferguson MW. Recommendations on clinical proof of efficacy for potential scar prevention and reduction therapies. Wound Repair Regen 2011;19:s32–s37.
XXI. Dhivya S, Padma VV, Santhini E. Wound dressings - a review. Biomedicine (Taipei) 2015 Dec;5(4):22.
XXII. Kang BS, Na YC, Jin YW. Comparison of the wound healing effect of cellulose and jelatin: an in vivo study. Arch Plast Surg 2012;39:317–21.
XXIII. Shin HS, Oh HY. The effect of trombosit-rich plasma on wounds of OLETF rats using expression of matrix metalloproteinase-2 and -9 mRNA. Arch Plast Surg 2012;39:106–12.
XXIV. Daunton C, Kothari S, Smith L, Steele D. A history of materials and practices for wound management. Wound Pract Res 2012;20:1748–6
XXV. Molan P, Rhodes T. Honey: a biologic wound dressing. Wounds 2015;27(6):141-51
XXVI. Atkinson JA, McKenna KT, Barnett AG, McGrath DJ, Rudd M. A randomized, controlled trial to determine the efficacy of paper tape in preventing hypertrophic scar formation in surgical incisions that traverse Langer's skin tension lines. Plast Reconstr Surg 2005;116:1648–56.
XXVII. Verhaegen PD, van Zuijlen PP, Pennings NM, van Marle J, Niessen FB, van der Horst CM, Middelkoop E. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis. Wound Repair Regen 2009;17:649–56.
XXVIII. Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician 2009;80:253–60.
XXIX. Chang CC, Kuo YF, Chiu HC, Lee JL, Wong TW, Jee SH. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J Surg Res 1995;59:705–11.
XXX. Borgognoni L. Biological effects of silicone jel sheeting. Wound Repair Regen 2002;10:118–21.
XXXI. Sawada Y, Sone K. Treatment of scars and keloids with a cream containing silicone oil. Br J Plast Surg 1990;43:683–8.
XXXII. Tang YW. Intra- and postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg 1992;45:371–3.
XXXIII. Rosen DJ, Patel MK, Freeman K, Weiss PR. A primary protocol for the management of ear keloids: results of excision combined with intraoperative and postoperative steroid injections. Plast Reconstr Surg 2007;120:1395–400.
XXXIV. Wong TS, Li JZH, Gao W. The efficacy of triamcinolone acetonide in keloid treatment: a systematic review and meta-analysis. Front Med (Lausanne) 2018;3:71
XXXV. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999;104:1435–58.
XXXVI. Pruimboom T, Scheltinga MR. Keloid formation due to repetitive mammographies. Case Rep Dermatol 2018;10:257-62.
XXXVII. Appleton I, Brown NJ, Willoughby DA. Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol 1996;149:1441–7.
XXXVIII. Ladin DA, Hou Z, Patel D, McPhail M, Olson JC, Saed GM, Fivenson DP. P53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 1998;6:28–37.
XXXIX. DiPietro LA. Angiogenesis and scar formation in healing wounds. Curr Opin Rheumatol 2013;25:87–91.
XL. Huang C, Akaishi S, Ogawa R. Mechanosignaling pathways in cutaneous scarring. Arch Dermatol Res2012;304:589–97.
XLI. Sarrazy V, Billet F, Micallef L, Coulomb B, Desmoulière A. Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen 2011;19:s10–s15.
XLII. Bouzari N, Davis SC, Nouri K. Laser treatment of keloids and hypertrophic scars. Int J Dermatol 2007;46:80–8.
XLIII. Parrett BM, Donelan MB. Pulsed dye laser in burn scars: current concepts and future directions. Burns 2010;36:443–9.
XLIV. Rohrich RJ, Zbar RI. A simplified algorithm for the use of Z-plasty. Plast Reconstr Surg 1999 Apr;103(5):1513-7.
XLV. Goutos I, Yousif AH, Ogawa R. W-plasty in scar revision: geometrical considerations and suggestions for site-specific design modifications. Plast Reconstr Surg Glob Open 2019 Apr 2;7(4):e2179
XLVI. Son DG, Lee HG, Han KH, Kim JH. Radiation therapy following total keloidectomy; a preliminary report. J Korean Soc Plast Reconstr Surg 2005;32:717–22.
XLVII. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 2004;30:54–6.
XLVIII. Tziotzios C, Profyris C, Sterling J. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures J Am Acad Dermatol 2012;66:13–24.
XLIX. Occleston NL, Fairlamb D, Hutchison J, O'Kane S, Ferguson MW. Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area. Expert Opin Investig Drugs 2009;18:1231–9.
L. Jackson WM, Nesti LJ, Tuan RS. Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther 2012;3:20.
LI. Sung HM, Suh IS, Lee HB, Tak KS, Moon KM, Jung MS. Case reports of adipose-derived stem cell therapy for nasal skin necrosis after filler injection. Arch Plast Surg 2012;39:51–4.
LII. Yang JD, Choi DS, Cho YK, Kim TK, Lee JW, Choi KY, Chung HY, Cho BC, Byun JS. Effect of amniotic fluid stem cells and amniotic fluid cells on the wound healing process in a white rat model. Arch Plast Surg 2013;40:496–504.